title: Episodic withdrawal promotes psychomotor sensitization to morphine.
abstract: The relative intermittency or continuity of drug delivery is a major determinant of addictive liability, and also influences the impact of drug exposure on brain function and behavior. Events that occur during the offset of drug action (ie, acute withdrawal) may have an important role in the consequences of intermittent drug exposure. We assessed whether recurrent episodes of acute withdrawal contribute to the development of psychomotor sensitization in rodents during daily morphine exposure. The acoustic startle reflex--a measure of anxiety induced by opiate withdrawal-was used to resolve and quantify discrete withdrawal episodes, and pharmacological interventions were used to manipulate withdrawal severity. Startle potentiation was observed during spontaneous withdrawal from a single morphine exposure, and individual differences in initial withdrawal severity positively predicted the subsequent development of sensitization. Manipulations that reduce or exacerbate withdrawal severity also produced parallel changes in the degree of sensitization. These results demonstrate that the episodic experience of withdrawal during daily drug exposure has a novel role in promoting the development of psychomotor sensitization--a prominent model of drug-induced neurobehavioral plasticity. Episodic withdrawal may have a pervasive role in many effects of intermittent drug exposure and contribute to the development of addiction.
authors.affiliation: Graduate Program in Neuroscience and Departments of Neuroscience and Psychology, University of Minnesota, Minneapolis, MN, USA.
authors.forename: Patrick E
authors.initials: PE
authors.lastname: Rothwell
authors.forename: Jonathan C
authors.initials: JC
authors.lastname: Gewirtz
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Thomas
mesh_terms: D000161:Acoustic Stimulation / Q000379:methods; D000818:Animals; D004347:Drug Interactions; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013216:Reflex, Startle / Q000187:drug effects*; D013997:Time Factors
chemical_list: D009270:Naloxone; D009020:Morphine
references.citation: J Pharmacol Exp Ther. 2003 Feb;304(2):603-9
references.pmid: 12538812
references.citation: Psychopharmacology (Berl). 2002 Nov;164(3):318-28
references.pmid: 12424556
references.citation: Neuron. 1997 Sep;19(3):591-611
references.pmid: 9331351
references.citation: Am J Psychiatry. 2007 Aug;164(8):1149-59
references.pmid: 17671276
references.citation: Annu Rev Psychol. 2003;54:25-53
references.pmid: 12185211
references.citation: Behav Brain Res. 1997 Mar;84(1-2):225-39
references.pmid: 9079787
references.citation: Neuropharmacology. 2004;47 Suppl 1:167-79
references.pmid: 15464135
references.citation: Neuropsychopharmacology. 2009 Sep;34(10):2285-95
references.pmid: 19494807
references.citation: Neuropsychopharmacology. 2004 Jul;29(7):1312-20
references.pmid: 15039768
references.citation: Synapse. 1993 Jul;14(3):243-5
references.pmid: 8211708
references.citation: J Pharmacol Exp Ther. 1975 Dec;195(3):499-504
references.pmid: 1195133
references.citation: Brain Res. 2010 Feb 16;1314:139-44
references.pmid: 19891960
references.citation: Pain. 1997 Apr;70(2-3):125-32
references.pmid: 9150285
references.citation: Psychopharmacology (Berl). 2005 Apr;178(4):367-80
references.pmid: 15765253
references.citation: Brain Res. 2000 Sep 29;878(1-2):20-31
references.pmid: 10996133
references.citation: Brain Res. 1986 Jun;396(2):157-98
references.pmid: 3527341
references.citation: Trends Pharmacol Sci. 2005 Feb;26(2):82-7
references.pmid: 15681025
references.citation: Arch Intern Med. 1966 Oct;118(4):304-9
references.pmid: 4162686
references.citation: Pharmacol Biochem Behav. 2007 May;87(1):171-8
references.pmid: 17524462
references.citation: J Neurosci. 2001 Jun 1;21(11):4074-80
references.pmid: 11356895
references.citation: J Neurosci. 2004 Oct 20;24(42):9414-24
references.pmid: 15496677
references.citation: Neuropsychopharmacology. 2005 Sep;30(9):1662-9
references.pmid: 15726114
references.citation: Addict Behav. 2003 Jun;28(4):817-21
references.pmid: 12726795
references.citation: Pharmacol Biochem Behav. 1992 Sep;43(1):243-8
references.pmid: 1409810
references.citation: J Consult Clin Psychol. 1993 Oct;61(5):743-50
references.pmid: 8245272
references.citation: Trends Neurosci. 2002 Dec;25(12):610-5
references.pmid: 12446127
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):334-44
references.pmid: 19150477
references.citation: Psychopharmacology (Berl). 1988;96(1):110-5
references.pmid: 3147470
references.citation: Neuropsychopharmacology. 2002 Jan;26(1):18-26
references.pmid: 11751029
references.citation: Psychopharmacology (Berl). 2003 Jul;168(3):280-92
references.pmid: 12712232
references.citation: Annu Rev Neurosci. 2006;29:565-98
references.pmid: 16776597
references.citation: Psychopharmacology (Berl). 2005 Apr;178(4):353-66
references.pmid: 15696323
references.citation: Am J Psychiatry. 1999 Sep;156(9):1444-6
references.pmid: 10484960
references.citation: Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
references.pmid: 1665095
references.citation: J Neurosci. 2003 Sep 10;23(23):8360-9
references.pmid: 12967998
references.citation: J Neurosci. 1997 Aug 15;17(16):6434-46
references.pmid: 9236251
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Psychopharmacology (Berl). 2008 Mar;196(4):649-60
references.pmid: 18026718
references.citation: Life Sci. 1982 Oct 11;31(15):1531-40
references.pmid: 6890614
references.citation: J Neurosci. 1996 Mar 1;16(5):1957-63
references.pmid: 8774462
references.citation: Neuropsychopharmacology. 2007 Nov;32(11):2290-300
references.pmid: 17314916
references.citation: Neuroscience. 1997 Jan;76(1):167-76
references.pmid: 8971769
references.citation: J Pharmacol Exp Ther. 1977 Apr;201(1):44-54
references.pmid: 557543
references.citation: Science. 1981 May 22;212(4497):943-5
references.pmid: 7195068
references.citation: J Neurosci. 2005 Jun 1;25(22):5389-96
references.pmid: 15930388
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):105-35
references.pmid: 19693004
references.citation: Neuropsychopharmacology. 2004 Sep;29(9):1664-74
references.pmid: 15138436
references.citation: Neuropharmacology. 1978 Dec;17(12):1081-4
references.pmid: 570650
references.citation: Neurosci Biobehav Rev. 2004 Jan;27(8):827-39
references.pmid: 15019432
references.citation: Brain Res. 1993 Oct 1;623(2):341-4
references.pmid: 8221119
references.citation: Psychol Rev. 2004 Jan;111(1):33-51
references.pmid: 14756584
references.citation: Behav Neurosci. 1995 Feb;109(1):91-105
references.pmid: 7734084
references.citation: Behav Brain Res. 2008 Jun 26;190(1):119-23
references.pmid: 18378328
references.citation: Neuropsychopharmacology. 2003 Nov;28(11):1960-72
references.pmid: 12915862
references.citation: J Pharmacol Exp Ther. 1987 Apr;241(1):204-12
references.pmid: 3572784
references.citation: J Abnorm Psychol. 2005 May;114(2):223-34
references.pmid: 15869353
references.citation: Psychopharmacology (Berl). 2004 Jan;171(2):140-7
references.pmid: 13680079
references.citation: Behav Pharmacol. 1993;4(4):289-312
references.pmid: 11224198
references.citation: J Pharmacol Exp Ther. 1995 May;273(2):808-15
references.pmid: 7752084
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: J Neurosci. 2001 Sep 15;21(18):7397-403
references.pmid: 11549750
references.citation: Eur J Pharmacol. 1996 Mar 28;299(1-3):33-9
references.pmid: 8901005
references.citation: J Neurosci. 1996 Jan;16(1):274-82
references.pmid: 8613793
references.citation: J Pharmacol Exp Ther. 1987 Oct;243(1):281-7
references.pmid: 3668859
references.citation: Psychopharmacology (Berl). 2004 Oct;175(4):428-35
references.pmid: 15175841
references.citation: Behav Brain Res. 2007 Dec 11;185(1):49-58
references.pmid: 17692933
references.citation: Br J Pharmacol. 1972 Oct;46(2):213-24
references.pmid: 4651770
references.citation: Psychopharmacology (Berl). 2000 Apr;149(2):115-20
references.pmid: 10805605
references.citation: Pharmacol Biochem Behav. 1998 Nov;61(3):331-3
references.pmid: 9768568
references.citation: Neuropsychopharmacology. 1998 Mar;18(3):222-32
references.pmid: 9471119
references.citation: Life Sci. 1980 Apr 21;26(16):1275-82
references.pmid: 6991841
references.citation: Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120
references.pmid: 10972458
references.citation: Nat Neurosci. 2007 Jan;10(1):93-9
references.pmid: 17143271
references.citation: Sci Am. 1982 Mar;246(3):128-41
references.pmid: 7043731
references.citation: Science. 2009 Jul 10;325(5937):207-10
references.pmid: 19590003
references.citation: Neuroscience. 2007 Nov 30;150(1):8-13
references.pmid: 17961928
references.citation: Alcohol. 2000 Aug;22(1):19-24
references.pmid: 11109024
references.citation: Neuropharmacology. 2008 Mar;54(3):475-86
references.pmid: 18082850
references.citation: Psychopharmacology (Berl). 1997 May;131(2):115-22
references.pmid: 9201798
references.citation: Psychopharmacology (Berl). 2008 Apr;197(2):203-16
references.pmid: 18097654
references.citation: Brain Res. 1991 Aug 30;558(1):163-5
references.pmid: 1933379
references.citation: Nat Rev Neurosci. 2007 Nov;8(11):844-58
references.pmid: 17948030
references.citation: Eur J Neurosci. 1998 Nov;10(11):3565-71
references.pmid: 9824469
references.citation: Mol Psychiatry. 2004 Jun;9(6):557-69
references.pmid: 15098002
references.citation: Psychopharmacology (Berl). 2009 Nov;207(1):13-25
references.pmid: 19669732
references.citation: Eur J Neurosci. 1998 Feb;10(2):782-5
references.pmid: 9749743
references.citation: J Neurochem. 2005 Feb;92(3):536-45
references.pmid: 15659224
references.citation: J Neurosci. 2006 Aug 16;26(33):8549-58
references.pmid: 16914681
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Psychopharmacology (Berl). 2001 Jun;156(1):98-107
references.pmid: 11465640
references.citation: Psychopharmacology (Berl). 1993;112(4):511-7
references.pmid: 7871065
references.citation: Pharmacol Biochem Behav. 2004 Dec;79(4):661-9
references.pmid: 15582674
references.citation: Psychopharmacology (Berl). 2004 Feb;171(4):398-404
references.pmid: 13680070
references.citation: Neurosci Biobehav Rev. 2004 Jan;27(8):739-49
references.pmid: 15019424